NetworkNewsBreaks – Pressure BioSciences, Inc.
Post# of 1354
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its receipt of an order for the 12th and final system scheduled to be built in the Company’s initial manufacturing run of its revolutionary BaroShear(TM) K45 processing system. The BaroShear K45, based on the Company’s proprietary Ultra Shear Technology(TM) (UST(TM)) platform, is a unique and powerful nanoemulsification system designed to resolve one of today’s most critical problems facing the global hemp-derived cannabinoid industry: how to make hemp-derived cannabinoid oil effectively soluble in water, to optimize absorption and bioavailability when consumed or applied. “We are extremely gratified and excited that the initial manufacturing run of our BaroShear K45 processing systems has sold out,” PBI CEO and President Richard T. Schumacher said in the news release. “We are also pleased that an impressive, up-and-coming company like Canopy CBD Farms was able to participate in and place an order for the final available unit in our first manufacturing run. We are confident that the BaroShear K45 will differentiate them in the marketplace with a substantial advantage over their competition.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer